The expanded reimbursement access aims to make the FDA-cleared device more affordable for patients with conditions linked to hypoxia.
Key takeaways:
- Eligible patients can now access the OxiWear continuous oxygen measuring device through Medicare and participating insurance providers.
- The FDA-cleared prescription wearable provides continuous blood oxygen measurement and real-time low-oxygen alerts during both motion and rest.
- OxiWear demonstrated high performance across diverse skin tones during the FDA review process, addressing disparities in pulse oximetry accuracy.
Eligible patients may now access OxiWear’s continuous oxygen measuring device through Medicare and participating insurance providers. This expansion helps increase access for individuals living with chronic respiratory, cardiovascular, and other conditions with associated hypoxia.
OxiWear is a US Food and Drug Administration-cleared wearable device designed to provide continuous blood oxygen measurement and real-time low-oxygen alerts during both motion and rest. The device enables patients and healthcare providers to identify oxygen desaturation that may otherwise go undetected
“I started OxiWear as a personal mission to help people like me live life to the fullest despite the challenges of living with conditions that put us at risk of low oxygen levels,” says Shavini Fernando, founder and CEO of OxiWear, in a release. “Since receiving FDA clearance, one of our biggest priorities has been solving the reimbursement challenge and ensuring patients can access this technology without creating an additional financial burden. I’m incredibly proud that we’ve been able to work through those barriers and make OxiWear available through insurance coverage. Now, more patients can access the continuous oxygen data they need with greater affordability and peace of mind.”
Cleared for both clinical and at-home settings, OxiWear demonstrated high performance across diverse skin tones during the FDA review process. This addresses longstanding concerns regarding disparities in pulse oximetry accuracy and ensures more equitable oxygen measurement for all patients.
By expanding reimbursement access, OxiWear aims to improve patient outcomes, reduce avoidable hospitalizations, lower healthcare costs, and provide greater peace of mind for patients, caregivers, and healthcare providers.
